Page title
Search SAMHSA Publications and Digital Products
Store Facets Summary
- Clear all filters
- Remove Public Officials
- Remove Non-Profits & Faith-Based Organizations
- Remove People with Substance Use or Abuse Problems as Population Group
- Remove People in the Juvenile Justice System
- Remove People with Co-Occurring Disorders
- Remove Practice Guidelines
- Remove Evidence-Based Practices
- Remove Process Improvement
- Remove Protection & Advocacy
- Remove Health & Health Care-Related Laws
Main page content
Finding Quality Treatment for Substance Use Disorders (Spanish Version)
Published: June 2018
Esta hoja informativa se puede usar como una guía para las personas que buscan tratamiento de salud mental. Ofrece tres pasos necesarios para llevar a cabo antes de utilizar un centro de tratamiento, así como las cinco señales de un centro de tratamiento de calidad, que incluye revisar la acreditación, la medicación, las prácticas basadas en la evidencia, el papel de las familias y las redes de apoyo.
Finding Quality Treatment for Substance Use Disorders
Published: April 2018
This fact sheet serves as a guide for individuals seeking behavioral health treatment. It provides three necessary steps to complete prior to utilizing a treatment center and the five signs of a quality treatment center, which include a review of the accreditation, medication, evidence-based practices, position on the role of families, and support networks.
The Way Forward: Federal Action for a System That Works for All People Living With SMI and SED and Their Families and Caregivers – Full Report
Published: December 2017
This report shines the spotlight on the critical issues and services for Americans with serious mental illnesses (SMI) and serious emotional disturbances (SED), and the importance of concerted efforts by the federal government to address their needs. The report presents the current status of federal activities and a summary of advances in the care and treatment of people with SMI and SED. The report describes key advances in research and strategies to improve services to these individuals based on presentations given by the Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC) members at the first ISMICC meeting.
The Way Forward: Federal Action for a System That Works for All People Living With SMI and SED and Their Families and Caregivers – Executive Summary
Published: December 2017
This Executive Summary to the 2017 report to Congress shines the spotlight on the critical issues and services for Americans with serious mental illnesses (SMI) and serious emotional disturbances (SED). The 2017 report to congress represents the starting point in a five-year process of improving the lives of people with SMI and SED. This 8-page summary delineates the five focus areas, each with 8-10 recommendations. These recommendations are from the non-federal members and represent common areas in which federal partners and stakeholders can work together to implement over the next five years.
Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health - Executive Summary
Published: November 2016
This executive summary of the Surgeon General's Report on Alcohol, Drugs, and Health addresses alcohol, illicit drugs, and prescription drug misuse in the United States. Chapters of the report cover neurobiology, prevention, treatment, recovery, health systems integration, and recommendations for the future.
Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health - Full Report
Published: November 2016
This Surgeon General's Report on Alcohol, Drugs, and Health addresses the prevalence of alcohol, illicit drugs, and prescription drug misuse in the United States. Chapters of the report cover neurobiology, prevention, treatment, recovery, health systems integration, and recommendations for the future.
Adult Drug Courts and Medication-Assisted Treatment for Opioid Dependence
Published: September 2014
This guide highlights the use of medication-assisted treatment (MAT) for opioid use disorder in drug courts. It reviews effective medications, including methadone, buprenorphine, and naltrexone. The guide also provides strategies to increase the use of MAT in drug court programs.